Autologous Platelets Rich Plasma (APRP) Treatment Vs Saline Dressing for the Management of Diabetic Foot Ulcer
APRP
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of this study is to compare between the platelet rich plasma and normal saline dressing in the healing diabetic foot ulcers. It will be a randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2018
CompletedFirst Posted
Study publicly available on registry
October 23, 2018
CompletedOctober 23, 2018
October 1, 2018
8 months
July 11, 2018
October 21, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Wound Healing
complete healing of diabetic foot
8 to 12 weeks
Study Arms (2)
Autologous Platelets Rich Plasma
ACTIVE COMPARATORIn this group we will be managing diabetic wounds with platelet rich plasma treatment.
Conventional Saline dressing
ACTIVE COMPARATORIn this group we will be managing diabetic wounds with normal saline dressing.
Interventions
For PRP preparation 10 mL of the patient blood was collected. The blood was centrifuged at 2000 rpm for 5 min to obtain plasma. Then, this plasma was centrifuged at 3000 rpm for another 5 min to collect platelets. Platelets were diluted in 5 mL plasma to form PRP.
saline dressing of diabetic wounds will be done
Eligibility Criteria
You may qualify if:
- Diabetic foot wound less than 5cm in greatest diameter Non healing duration greater than 3 months Non infected Palpable distal pulses
You may not qualify if:
- Infected wound Wound greater than 5 cm Patient having HBa1c greater than 8% Renal failure Wound with bone exposed or having osteomyelitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Services hospital
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mahmmood Ayyaz, mbbs, fcps
Services Hospital, Lahore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
July 11, 2018
First Posted
October 23, 2018
Study Start
January 1, 2018
Primary Completion
August 30, 2018
Study Completion
August 30, 2018
Last Updated
October 23, 2018
Record last verified: 2018-10